Enliven Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
USD
40.75
0.46 (1.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
1.14%
0.84%
1W
-2.28%
2.33%
1M
-5.08%
9.08%
YTD
164.61%
8.08%
1Y
118.73%
30.63%
3Y
112.9%
78.8%
5Y
40.52%
74.81%
10Y
%
259.67%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
38.51%
0%
38.51%
6 Months
131.14%
0%
131.14%
1 Year
118.73%
0%
118.73%
2 Years
66.39%
0%
66.39%
3 Years
112.9%
0%
112.9%
4 Years
689.73%
0%
689.73%
5 Years
40.52%
0%
40.52%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary